See also this year's filing and all EDGAR filings for this company.
PDF Report 0000109657_2023_GT_Biopharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000109657, GT Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 16,562,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 174,000 |
| 4 | LiabilitiesCurrent | 4,938,000 |
| 5 | LiabilitiesNoncurrent | 64,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,446,000 |
| 9 | ResearchAndDevelopmentExpense | 8,811,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 373,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 16,736,000 |
| 1 | Liabilities | 5,002,000 |
| 2 | Expenses | 21,257,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 11,734,000 |
| 5 | NetIncome | -20,884,000 |
| 6 | ComprehensiveNetIncome | -20,884,000 |
| 7 | BaseVar | 21,684,000 |
| 8 | EconomicCapitalRatio | -0.0645 |
Edgar->Model Mapping
Feature Distribution
Change over Time
